#United States #New York #Class Action #Gross Law Firm #Regencell Bioscience

Shareholder Alert for Regencell Bioscience Holdings Limited

On May 5, 2026, The Gross Law Firm announced important information for shareholders of Regencell Bioscience Holdings Limited (NASDAQ: RGC). This announcement comes as part of a significant class action lawsuit that could impact many investors who have recently engaged with the company.

Background Information

During the period from October 28, 2024, to October 31, 2025, shareholders who purchased RGC's stock may have experienced serious financial risks due to alleged misleading statements made by the company. The lawsuit details various violations, asserting that Regencell was susceptible to market manipulation, which consequently led to increased volatility in its ordinary shares, exposing investors to substantial financial damage. Furthermore, it is believed that these misleading public statements contributed to a greater risk of regulatory scrutiny and damaging legal undertakings against the company.

Details of the Allegations

The main allegations in the class action lawsuit highlight that during the aforementioned class period:
1. Regencell’s management supplied information that was materially false and/or misleading.
2. Investors were not adequately informed about the vulnerability of the company to market manipulation.
3. As a result of these misleading claims, investors faced significant financial risks, with many suffering substantial losses.

Next Steps for Shareholders

The Gross Law Firm encourages affected investors to take immediate action. If investors are contemplating joining the class action, they can register by visiting the firm’s website. The deadline to secure lead plaintiff status is set for June 23, 2026. However, it’s crucial to note that individuals do not need to secure this status in order to benefit from the lawsuit. Once registered, shareholders will gain access to portfolio monitoring tools, keeping them updated on the case's progress.

Why Work with The Gross Law Firm?

The Gross Law Firm is recognized across the nation for its expertise in handling class action lawsuits. Their mission is to advocate for investors whose rights have been compromised due to corporate negligence, deceit, or illegal practices. The firm stands ready to pursue compensation for investors who have suffered losses due to these practices and is dedicated to holding companies accountable for their actions. Their commitment stems from a desire to uphold fair business practices and promote responsible corporate behavior.

Shareholders who are impacted by these events should not hesitate to reach out to The Gross Law Firm for support and guidance. They can contact the firm directly via phone at (646) 453-8903 or email at [email protected] The firm prides itself on its dedication to defending the rights of investors across various sectors, reaffirming the importance of investor protection in today's financial landscape.

This situation serves as a reminder of the pervasive risks within the investment landscape and underscores the importance of staying informed and vigilant in deciphering corporate communications. As the class action progresses, affected investors are encouraged to remain proactive to safeguard their financial interests.

Conclusion

In conclusion, shareholders of Regencell Bioscience Holdings Limited should take heed of this urgent notification regarding the ongoing class action lawsuit. As the deadline for participation approaches, the time for action is now. For additional information or to register for updates, interested parties should visit the specified link for further details.